首页> 外国专利> NEW RIBOSOMAL TARGETS FOR ANTIBIOTIC DRUG DISCOVERY

NEW RIBOSOMAL TARGETS FOR ANTIBIOTIC DRUG DISCOVERY

机译:核糖体药物发现的新核糖体靶标

摘要

The present invention relates to methods to identify molecules that binds in the neomycin binding pocket of a bacterial ribosome using structures of an intact bacterial ribosome that reveal how the ribosome binds tRNA in two functionally distinct states, determined by x-ray crystallography. One state positions tRNA in the peptidyl-tRNA binding site. The second, a fully rotated state, is stabilized by ribosome recycling factor (RRF) and binds tRNA in a highly bent conformation in a hybrid peptidyl/exit (P/E) site. Additionally, the invention relates to various assays, including single-molecule assay for ribosome recycling, and methods to identify compounds that interfere with ribosomal function by detecting newly identified intermediate FRET states using known and novel FRET pairs on the ribosome. The invention also provides vectors and compositions with an N-terminally tagged S13 protein
机译:本发明涉及使用完整的细菌核糖体的结构鉴定结合在细菌核糖体的新霉素结合口袋中的分子的方法,该结构揭示了核糖体如何以两种功能不同的状态结合tRNA,这是通过X射线晶体学测定的。一种状态将tRNA定位在肽基-tRNA结合位点。第二种是完全旋转的状态,由核糖体回收因子(RRF)稳定,并在杂合肽基/出口(P / E)位点以高度弯曲的构型结合tRNA。另外,本发明涉及各种测定法,包括用于核糖体再循环的单分子测定法,以及通过使用核糖体上的已知和新颖的FRET对检测新近鉴定的中间FRET状态来鉴定干扰核糖体功能的化合物的方法。本发明还提供了具有N末端标记的S13蛋白的载体和组合物

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号